Showing results (1221-1230 of 9,122) with videos related to
Sort By:
Pageof 913
Cancer Medicine|March 29, 2022
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimensWei-Li Ma, Chia-Chi Lin, Feng-Ming Hsu, et al.Cancer Medicine|March 28, 2022
Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencingFumishi Kishigami, Yosuke Tanaka, Yoko Yamamoto, et al.Cancer Medicine|July 3, 2019
Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphomaEsther Hian Li Chan, Liang Piu Koh, Joanne Lee, et al.Cancer Medicine|March 1, 2022
The impact of tumor size on the survival of patients with small renal masses: A population-based studyYiming Tang, Fei Liu, Xiaopeng Mao, et al.Cancer Medicine|September 22, 2021
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safetyAna Oaknin, Amit M Oza, Domenica Lorusso, et al.Cancer Medicine|May 31, 2019
Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United StatesShaum M Kabadi, Ravi K Goyal, Saurabh P Nagar, et al.Cancer Medicine|June 1, 2019
CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcomaQicai Han, Chao Li, Yuan Cao, et al.Cancer Medicine|September 21, 2021
Does timing matter in radiotherapy of hepatocellular carcinoma? An experimental study in miceSoha A Hassan, Amira A H Ali, Dennis Sohn, et al.Cancer Medicine|September 21, 2021
Treatment resistance analysis reveals GLUT-1-mediated glucose uptake as a major target of synthetic rocaglates in cancer cellsJulia Sieber-Frank, Hans-Jürgen Stark, Simon Kalteis, et al.Cancer Medicine|September 21, 2021
Identification of colon tumor marker NKD1 via integrated bioinformatics analysis and experimental validationYue Wang, Chunxia Yang, Wenjing Li, et al.Pageof 913